Shanghai Majorbio Pharmaceutical Technology

Provider of genome sequencing and genomic technology services

placeShanghai, Shanghai, China calendar_todayFounded 2009 groups700 employees language majorbio.com

Web presence

Audience by country — top 5 markets by share of visits.

CountryShare
China87.8%
United States8.4%
Japan1.8%
Hong Kong0.7%
Singapore0.7%

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital267%
Private equity133%

Share of voice

Share of voice in China: 100% of web traffic across its competitive set; worldwide: 36.7%.

Coming soon